Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00777556 · ClinicalTrials.gov registry record · Phase 3
Emergency Contraception Actual Use Study
A Phase 3 study, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 343
- Enrollment target
NCT00777556 is a Phase 3 study that has completed, run by Duramed Research. The registered enrollment target is 343 participants.
The verdict
NCT00777556, a Phase 3 study, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 343 participants
- Enrollment target
Study Summary
This is a non-comparative case series study to assess the ability of females 11-16 years of age, inclusive, who are requesting emergency contraception (EC) to use the study product, DR-104 (Plan B® 1.5), appropriately and safely without provider counseling.
Interventions
- DRUG DR-104
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 343 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00777556
The ClinicalTrials.gov registry entry for NCT00777556 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 343 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duramed Research, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DR-104 is the first listed.
NCT00777556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00777556 about?
NCT00777556 is a clinical study titled "Emergency Contraception Actual Use Study". This is a non-comparative case series study to assess the ability of females 11-16 years of age, inclusive, who are requesting emergency contraception (EC) to use the study product, DR-104 (Plan B® 1.5), appropriately and safely without provider counseling.
What is the current status of trial NCT00777556?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 343 participants. The study started on 2008-10. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00777556?
The interventions under investigation include: DR-104 (DRUG).
Who is sponsoring clinical trial NCT00777556?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.